TETRAGENEX PHARMACEUTICALS, INC. - FORM 10-K - EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - April 15, 2010

Attached files

file filename
EX-31.1 - CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - TETRAGENEX PHARMACEUTICALS, INC.ttrx10k20091231ex31-1.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - TETRAGENEX PHARMACEUTICALS, INC.ttrx10k20091231ex32-1.htm
10-K - TETRAGENEX PHARMACEUTICALS, INC. FORM 10-K DECEMBER 31, 2009 - TETRAGENEX PHARMACEUTICALS, INC.ttrx10k20091231.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - TETRAGENEX PHARMACEUTICALS, INC.ttrx10k20091231ex31-2.htm
EXHIBIT 32.2
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report of TETRAGENEX PHARMACEUTICALS, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Neil Martucci, Chief Financial Officer, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act, that:
 
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
TETRAGENEX PHARMACEUTICALS, INC.
 
 
 
By:
/s/ Neil Martucci                    
   
Neil Martucci
   
Chief Financial Officer
     
  April 15, 2010
 
 

TETRAGENEX PHARMACEUTICALS, INC. Reports